Megacap Stocks After Microsoft's Latest Pullback: Top Picks
After Microsoft's pullback, savvy investors look for durable megacap ideas. This guide highlights three top megacap s...
The debate between points and cash back is ongoing. Understand the benefits of each to determine which suits you best.
28,655 articlesAfter Microsoft's pullback, savvy investors look for durable megacap ideas. This guide highlights three top megacap s...
As Liquidia releases its Q4 2025 results, investors crave clarity on revenue, burn rate, and milestones. This article...
Two cloud software giants sit side by side in the growth-at-any-cost debate. This article breaks down whether should ...
Geopolitical tensions and volatile oil prices have investors hunting for stock-wue winners beyond crude. Here are two...
Rival AI employees have filed an amicus brief backing Anthropic in a Pentagon-led dispute over a supply-chain risk de...
A new analysis shows Microsoft’s AI-driven revenue pace hitting fresh highs, suggesting meaningful upside for patient...
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
NVIDIA stock has fallen over the past month, triggering worries about headlines and momentum. This article breaks dow...
After months of stubborn pricing, the market shows a negative turn in home values. This shift changes the playbook fo...
Bitcoin has tumbled from its peak, leaving many investors unsure about the next move. This guide breaks down what the...
Greg Abel, seen as Warren Buffett's successor, made a bold move by trimming UnitedHealth from Berkshire's portfolio. ...
Investors are eyeing yuanbao (yb) 2026 earnings as the company pivots toward new revenue streams. This guide breaks d...